Key Metrics
CiteScore 

4.2
Impact Factor 

< 5
Scite Index 

0.86 5-Year SI

SJR 

Q2Pulmonary and Respiratory Medicine

SNIP 

1.23
Recommended pre-submission checks
Powered by 

Topics Covered on BMC Pulmonary Medicine
BMC Pulmonary Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2290 | USD 2790 | GBP 1990 |
| Publication Time | 23 |
| Editorial Review Process | Open peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in BMC Pulmonary Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in BMC Pulmonary Medicine
Real-world treatment and healthcare resource utilization patterns among patients with advanced non-small cell lung cancer treated with amivantamab: a retrospective study using insurance claims data.
- 14 May 2026
- BMC pulmonary medicine
Identification of risk factors and development of a predictive model for early renal impairment in patients with obstructive sleep apnea-hypopnea syndrome.
- 13 May 2026
- BMC pulmonary medicine
Factors associated with bronchiectasis in Sri Lanka: evidence from a multicenter case-control study in the Colombo District.
- 13 May 2026
- BMC pulmonary medicine
Remdesivir for the treatment of children hospitalized with COVID-19: a systematic review and meta-analysis.
- 13 May 2026
- BMC pulmonary medicine
Anti-Ro-52 antibody is a risk factor for recurrence in interstitial lung disease with positive anti-aminoacyl tRNA synthetase antibody: a single-center, retrospective observational study.
- 12 May 2026
- BMC pulmonary medicine
Is obstructive sleep apnea a driver of cancer and chronic disease risk? A real-world analysis of over 3million patients.
- 12 May 2026
- BMC pulmonary medicine
Real-world treatment and healthcare resource utilization patterns among patients with advanced non-small cell lung cancer treated with amivantamab: a retrospective study using insurance claims data.
- 14 May 2026
- BMC pulmonary medicine
Identification of risk factors and development of a predictive model for early renal impairment in patients with obstructive sleep apnea-hypopnea syndrome.
- 13 May 2026
- BMC pulmonary medicine
Factors associated with bronchiectasis in Sri Lanka: evidence from a multicenter case-control study in the Colombo District.
- 13 May 2026
- BMC pulmonary medicine
Remdesivir for the treatment of children hospitalized with COVID-19: a systematic review and meta-analysis.
- 13 May 2026
- BMC pulmonary medicine
Anti-Ro-52 antibody is a risk factor for recurrence in interstitial lung disease with positive anti-aminoacyl tRNA synthetase antibody: a single-center, retrospective observational study.
- 12 May 2026
- BMC pulmonary medicine
Is obstructive sleep apnea a driver of cancer and chronic disease risk? A real-world analysis of over 3million patients.
- 12 May 2026
- BMC pulmonary medicine